Jana Mašlanková Selected Research

5,6-dihydroxy-2-indolylcarboxylic acid

5/2019

Specific Urinary Metabolites in Malignant Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jana Mašlanková Research Topics

Disease

1	Carcinogenesis 06/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Pathologic Processes 01/2021
1	Diabetes Mellitus 06/2019
1	Melanoma (Melanoma, Malignant) 05/2019
1	Neoplasms (Cancer) 05/2019
1	Abdominal Obesity 01/2018
1	Infertility (Sterility) 05/2015

Drug/Important Bio-Agent (IBA)

1	RNA (Ribonucleic Acid)IBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 06/2021
1	Macromolecular SubstancesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Insulin (Novolin)FDA Link 06/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2019
1	5,6-dihydroxy-2-indolylcarboxylic acidIBA 05/2019
1	indoxylIBA 05/2019
1	AcidsIBA 05/2019
1	Melanins (Melanin)IBA 05/2019
1	Tryptophan (L-Tryptophan)FDA Link 05/2019
1	Tyrosine (L-Tyrosine)FDA Link 05/2019
1	Vanilmandelic Acid (Vanillylmandelic Acid)IBA 05/2019
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 01/2018
1	VLDL LipoproteinsIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	Monoamine Oxidase (MAO)IBA 05/2015
1	Selegiline (E250)FDA LinkGeneric 05/2015

Therapy/Procedure

1	Therapeutics 05/2015